ATP6AP2 and pancreatic ductal adenocarcinoma: Antibodies against the (pro)renin receptor residues 47–60 and 200–213 can inhibit pancreatic ductal adenocarcinoma (PDAC) cell proliferation by suppressing Wnt signaling.